Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

461

HTML

5759

Tables (1-3)

221

Sum=6441

Publishing Process of This Article

Item

Count

Browse

1171

Download

914

Sum=2085

Dec 21, 2013 (publication date) through Dec 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Dec 21, 2013; 19(47): 8887-8894
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8887

Table 2 Antiviral interventions for prevention of hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma

HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; IFN: Interferon; NA: Nucleotide analogs.

Citation: Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol 2013; 19(47): 8887-8894
URL: https://www.wjgnet.com/1007-9327/full/v19/i47/8887.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i47.8887